Cardiovalve Transfemoral Mitral Valve System

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Mitral Regurgitation
Interventions
DEVICE

Cardiovalve Transfemoral Mitral Valve

The Cardiovalve Transfemoral Mitral Valve System is intended for use symptomatic patients with severe mitral regurgitation who are at elevated risk for surgical mitral valve repair or replacement and who are anatomically eligible for transfemoral mitral valve replacement with transseptal access to the left atrium.

Trial Locations (2)

10032

Columbia University Medical Center/NYPH, New York

30309

Piedmont Heart Institute, Atlanta

Sponsors
All Listed Sponsors
collaborator

Cardiovalve Ltd.

INDUSTRY

collaborator

Cardiovascular Research Foundation, New York

OTHER

lead

Boston Biomedical Associates

OTHER

NCT03813524 - Cardiovalve Transfemoral Mitral Valve System | Biotech Hunter | Biotech Hunter